Product Images Efavirenz

View Photos of Packaging, Labels & Appearance

Figure 1 - efavirenz fig1
Figure 10 - efavirenz fig10
Figure 11 - efavirenz fig11
Figure 12 - efavirenz fig12
Figure 13 - efavirenz fig13
Figure 14 - efavirenz fig14
Figure 15 - efavirenz fig15
Figure 16 - efavirenz fig16
Figure 17 - efavirenz fig17
Figure 18 - efavirenz fig18
Figure 19 - efavirenz fig19
Figure 2 - efavirenz fig2
Figure 20 - efavirenz fig20
Figure 21 - efavirenz fig21
Figure 22 - efavirenz fig22
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (30 Capsule Bottle) - efavirenz fig23
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg Blister Carton (3 x 10 Unit-dose) - efavirenz fig24
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (30 Capsule Bottle) - efavirenz fig25
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg Blister Carton (3 x 10 Unit-dose) - efavirenz fig26
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (30 Capsule Bottle) - efavirenz fig27
PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg Blister Carton (3 x 10 Unit-dose) - efavirenz fig28
Figure 3 - efavirenz fig3
Figure 4 - efavirenz fig4
Figure 5 - efavirenz fig5
Figure 6 - efavirenz fig6
Figure 7 - efavirenz fig7
Figure 8 - efavirenz fig8
Figure 9 - efavirenz fig9
structure - efavirenz str

Product Label Images

The following 29 images provide visual information about the product associated with Efavirenz NDC 65862-105 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - efavirenz fig1

Figure 10 - efavirenz fig10

Figure 11 - efavirenz fig11

Figure 12 - efavirenz fig12

Figure 13 - efavirenz fig13

Figure 14 - efavirenz fig14

Figure 15 - efavirenz fig15

Figure 16 - efavirenz fig16

Figure 17 - efavirenz fig17

Figure 18 - efavirenz fig18

Figure 19 - efavirenz fig19

Figure 2 - efavirenz fig2

Figure 20 - efavirenz fig20

Figure 21 - efavirenz fig21

Figure 22 - efavirenz fig22

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg (30 Capsule Bottle) - efavirenz fig23

Each capsule contains 50 mg of efavirenz USP. Usual Dosage: See package insert for Rx-only Dosage and Administration. ALERT: Find out about medicines that should NOT be taken with Efavirenz Capsules USP. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Distributed by Aurobindo Pharma USA, Inc, 279 Princeton-Hightstown Road, East Windsor, NJ 08520. Made in India. Code: TS/DRUGS/19/1993.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 50 mg Blister Carton (3 x 10 Unit-dose) - efavirenz fig24

Efavirenz Capsules USP contain 50 mg of efavirenz and are used for treatment of HIV infection. The package insert contains information on dosage and administration. The capsules should be stored at room temperature, between 20-25°C. The package contains 30 capsules in 3x10 unit doses. The manufacturer is Aurobindo Pharma USA and the product is made in India.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (30 Capsule Bottle) - efavirenz fig25

This is a description of Efavirenz Capsules USP with NDC number 65862-105-30. It is available only with a prescription. The label has an alert asking to check other medicines that should not be taken while consuming Efavirenz Capsules USP. Each capsule contains 100 mg of efavirenz USP. The pharmacist should not cover the alert box with a pharmacy label. The recommended storage temperature is between 20° to 25°C (68° to 77°F), and excursions are allowed between 15° to 30°C (59° to 86°F). The manufacturer is Aurobindo Pharma USA, Inc based in New Jersey, USA. The product is made in India. No information is provided in the text regarding the usage or indications of Efavirenz Capsules USP, besides asking to refer to the package insert for dosage and administration instructions.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg Blister Carton (3 x 10 Unit-dose) - efavirenz fig26

Efavirenz Capsules USP is a medication that contains 100mg of efavirenz. The typical dosage is provided in the package insert, and it should be kept within a particular temperature range. The medication is packed in 30 capsules per box, and users must not take it with other drugs. The medicine label has a warning alert that should not be covered. The medication is produced in India by Aurobindo pharmaceuticals and retailed by TSIdrugs with product code 1911993.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg (30 Capsule Bottle) - efavirenz fig27

Each capsule contains 200mg of efavirenz USP. It is important to consult the package insert for dosage and administration instructions. Efavirenz Capsules USP should not be covered by the pharmacy label on the box. It is crucial to be aware of other medications that should not be taken with Efavirenz Capsules USP. The capsules should be stored between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Distributed by Aurobindo Pharma USA, Inc from East Windsor, NJ and Made in India. The available code is TS/DRUGS/19/1993. The rest of the text is not available.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 200 mg Blister Carton (3 x 10 Unit-dose) - efavirenz fig28

The text is describing a prescription medicine named Efavirenz Capsules USP. It comes in a pack containing 30 capsules placed in 3 unit-doses of 10 capsules each. Each capsule contains 2009 of USP, and the recommended dosage is mentioned as per physician's advice. There is an NDC code provided, and additional instructions provided for the pharmacist to not cover the ALERT box with pharmacy label. The medicine should not be taken with some other medicines. The details of the manufacturer are also present.*

Figure 3 - efavirenz fig3

Figure 4 - efavirenz fig4

Figure 5 - efavirenz fig5

Figure 6 - efavirenz fig6

Figure 7 - efavirenz fig7

Figure 8 - efavirenz fig8

Figure 9 - efavirenz fig9

structure - efavirenz str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.

Table of Contents